Investor Presentations

Biocon / Investor Relations / Financial Information / Investor Presentations

FINANCIAL INFORMATION Annual Reports Quarterly Reports Key Figures
(Annual & Quarterly) Earnings Call Recordings Earnings Call Transcript Subsidiary Financials Investor Presentation

FY 2025 - 26

Business Consolidation – Overview, December 09, 2025

Biocon Biologics at the 44th Annual J.P. Morgan Healthcare Conference – Presentation

Biocon Biologics at the 44th Annual J.P. Morgan Healthcare Conference – Audio Recording

FY 2024 - 25

Biocon Biologics at the 43rd Annual J.P. Morgan Healthcare Conference – Presentation

Biocon Biologics at the 43rd Annual J.P. Morgan Healthcare Conference – Audio Recording

Biocon Biologics Investor Presentation – September 2024

FY 2023 - 24

Biocon Biologics Investor Presentation – March 2024

FY 2021 - 22

Biocon Biologics – Acquisition of Viatris’ Biosimilar Business

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.